163 related articles for article (PubMed ID: 12678767)
1. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
Manderville RA
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
[TBL] [Abstract][Full Text] [Related]
2. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.
Ohkuma S; Sato T; Okamoto M; Matsuya H; Arai K; Kataoka T; Nagai K; Wasserman HH
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):731-41. PubMed ID: 9729483
[TBL] [Abstract][Full Text] [Related]
3. Influence of the a-ring on the redox and nuclease properties of the prodigiosins: importance of the bipyrrole moiety in oxidative DNA cleavage.
Melvin MS; Calcutt MW; Noftle RE; Manderville RA
Chem Res Toxicol; 2002 May; 15(5):742-8. PubMed ID: 12018997
[TBL] [Abstract][Full Text] [Related]
4. Influence of the a-ring on the proton affinity and anticancer properties of the prodigiosins.
Melvin MS; Tomlinson JT; Park G; Day CS; Saluta GR; Kucera GL; Manderville RA
Chem Res Toxicol; 2002 May; 15(5):734-41. PubMed ID: 12018996
[TBL] [Abstract][Full Text] [Related]
5. The prodigiosins: a new family of anticancer drugs.
Montaner B; Pérez-Tomás R
Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
[TBL] [Abstract][Full Text] [Related]
6. Prodigiosins as a new group of H+/Cl- symporters that uncouple proton translocators.
Sato T; Konno H; Tanaka Y; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
J Biol Chem; 1998 Aug; 273(34):21455-62. PubMed ID: 9705273
[TBL] [Abstract][Full Text] [Related]
7. Prodigiosins uncouple mitochondrial and bacterial F-ATPases: evidence for their H+/Cl- symport activity.
Konno H; Matsuya H; Okamoto M; Sato T; Tanaka Y; Yokoyama K; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
J Biochem; 1998 Sep; 124(3):547-56. PubMed ID: 9722664
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and immunosuppressive activity of novel prodigiosin derivatives.
D'Alessio R; Bargiotti A; Carlini O; Colotta F; Ferrari M; Gnocchi P; Isetta A; Mongelli N; Motta P; Rossi A; Rossi M; Tibolla M; Vanotti E
J Med Chem; 2000 Jun; 43(13):2557-65. PubMed ID: 10891115
[TBL] [Abstract][Full Text] [Related]
9. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue.
Tomlinson JT; Park G; Misenheimer JA; Kucera GL; Hesp K; Manderville RA
Org Lett; 2006 Oct; 8(21):4951-4. PubMed ID: 17020344
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-cancer activity of C-ring-functionalized prodigiosin analogues.
Regourd J; Ali AA; Thompson A
J Med Chem; 2007 Apr; 50(7):1528-36. PubMed ID: 17348639
[TBL] [Abstract][Full Text] [Related]
11. Prodigiosins as anti cancer agents: living upto their name.
Pandey R; Chander R; Sainis KB
Curr Pharm Des; 2009; 15(7):732-41. PubMed ID: 19275639
[TBL] [Abstract][Full Text] [Related]
12. Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products.
La JQ; Michaelides AA; Manderville RA
J Phys Chem B; 2007 Oct; 111(40):11803-11. PubMed ID: 17867672
[TBL] [Abstract][Full Text] [Related]
13. Synthetic prodigiosenes and the influence of C-ring substitution on DNA cleavage, transmembrane chloride transport and basicity.
Rastogi S; Marchal E; Uddin I; Groves B; Colpitts J; McFarland SA; Davis JT; Thompson A
Org Biomol Chem; 2013 Jun; 11(23):3834-45. PubMed ID: 23640568
[TBL] [Abstract][Full Text] [Related]
14. Influence of B-ring modifications on proton affinity, transmembrane anion transport and anti-cancer properties of synthetic prodigiosenes.
Marchal E; Rastogi S; Thompson A; Davis JT
Org Biomol Chem; 2014 Oct; 12(38):7515-22. PubMed ID: 25204645
[TBL] [Abstract][Full Text] [Related]
15. New insights on the antitumoral properties of prodiginines.
Pérez-Tomás R; Viñas M
Curr Med Chem; 2010; 17(21):2222-31. PubMed ID: 20459382
[TBL] [Abstract][Full Text] [Related]
16. Indoloprodigiosins from the C-10 bipyrrolic precursor: new antiproliferative prodigiosin analogs.
Baldino CM; Parr J; Wilson CJ; Ng SC; Yohannes D; Wasserman HH
Bioorg Med Chem Lett; 2006 Feb; 16(3):701-4. PubMed ID: 16289814
[TBL] [Abstract][Full Text] [Related]
17. The prodigiosins, proapoptotic drugs with anticancer properties.
Pérez-Tomás R; Montaner B; Llagostera E; Soto-Cerrato V
Biochem Pharmacol; 2003 Oct; 66(8):1447-52. PubMed ID: 14555220
[TBL] [Abstract][Full Text] [Related]
18. Prodigiosin-like pigments.
Gerber NN
CRC Crit Rev Microbiol; 1975 May; 3(4):469-85. PubMed ID: 1095305
[TBL] [Abstract][Full Text] [Related]
19. DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin.
Montaner B; Castillo-Avila W; Martinell M; Ollinger R; Aymami J; Giralt E; Pérez-Tomás R
Toxicol Sci; 2005 Jun; 85(2):870-9. PubMed ID: 15788728
[TBL] [Abstract][Full Text] [Related]
20. Prodigiosin and its potential applications.
Darshan N; Manonmani HK
J Food Sci Technol; 2015 Sep; 52(9):5393-407. PubMed ID: 26344956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
